Patients with axSpA who received UPA reported rapid and sustained improvements in total and nocturnal back pain over 12 weeks.

ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by ...

The following is a summary of “Validation of the Dutch version of the King’s Parkinson’s disease pain scale,” published in ...

Nonsurgical interventions like cognitive-behavioral therapy and mindfulness may reduce pain and disability in nonspecific ...

Chronic pain in India linked to suicide risk, overlooked in mental health assessments, highlighting need for integrated care.

BARCELONA -- Rheumatoid arthritis (RA) patients saw significant reductions in pain with transcranial direct current ...

A single 25 mg dose of psilocybin, paired with psychological support, brought lasting relief from depression and anxiety in ...

Over 200 adverse events were reported with a single injection of resiniferatoxin in 19 patients with refractory cancer pain. At least one adverse event occurred in all patients. Resiniferatoxin ...

Nike is navigating short-term pressures with bold innovation and channel integration, aiming for a FY26 turnaround and ...

A new study published in The New England Journal of Medicine Evidence showed that for patients with unmanageable cancer pain, single dose of intrathecal resiniferatoxin (RTX), an ...

Tonix Pharmaceuticals' TNX-102 SL nears FDA approval for fibromyalgia with positive trials. Find out why we recommend buying ...

Following recent discussions with Nike CEO Elliott Hill, the analyst highlights growing retailer enthusiasm for the 2026 ...